A Multicenter, Randomized, Phase 3 Study to Assess the Efficacy and Safety of INtratumorally Administered INT230-6 (SHAO, VINblastine, CIsplatin) Compared With US Standard of Care in Adult Participants With Locally Recurrent, InoperaBLE, or Metastatic Soft Tissue Sarcomas - (THE INVINCIBLE-3 TRIAL).

Datos básicos

ENSAYO CLÍNICO IT-03 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2024

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

INTENSITY THERAPEUTICS INC.

Compartir